Bremer Bank National Association’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,644
Closed -$278K 217
2022
Q2
$278K Sell
2,644
-6,875
-72% -$816K 0.05% 179
2022
Q1
$1.22M Sell
9,519
-13,584
-59% -$1.64M 0.2% 99
2021
Q4
$2.85M Buy
23,103
+1,485
+7% +$194K 0.47% 55
2021
Q3
$3.07M Sell
21,618
-502
-2% -$73.8K 0.61% 46
2021
Q2
$3.45M Sell
22,120
-90
-0.4% -$14.6K 0.74% 38
2021
Q1
$3.45M Buy
22,210
+65
+0.3% +$10.1K 0.79% 35
2020
Q4
$3.31M Buy
22,145
+274
+1% +$38.7K 0.79% 34
2020
Q3
$2.89M Sell
21,871
-258
-1% -$33.7K 0.76% 34
2020
Q2
$2.56M Buy
22,129
+150
+0.7% +$17.3K 0.73% 39
2020
Q1
$2.16M Buy
21,979
+387
+2% +$50.7K 0.62% 49
2019
Q4
$3.14M Sell
21,592
-76
-0.4% -$10.5K 0.68% 40
2019
Q3
$2.89M Sell
21,668
-435
-2% -$56.2K 0.64% 46
2019
Q2
$2.53M Buy
22,103
+470
+2% +$55K 0.55% 52
2019
Q1
$2.59M Buy
+21,633
New +$2.46M 0.51% 50

Other funds holding ZBH

Bremer Bank National Association's ZBH Position: Q3 2022 in Review

Bremer Bank National Association sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 2,644 shares — an estimated $278K sold.

Bremer Bank National Association first reported a position in ZBH in Q1 2019 and held it in 14 quarters. The position peaked at $3.45M in Q2 2021. 920 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • Bremer Bank National Association reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
  • Bremer Bank National Association sold 2,644 Zimmer Biomet shares in Q3 2022, an estimated $278K.
  • Bremer Bank National Association first reported a position in Zimmer Biomet in Q1 2019 and held it in 14 quarters.
  • Bremer Bank National Association's Zimmer Biomet position peaked at $3.45M in Q2 2021.
  • 920 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Bremer Bank National Association's 13F filing for Q3 2022, filed 12 Oct 2022.